Approval for manufacturing modifications to the avitene ultrafoam cast microfibrillar collagen hemostat (mch) sponge and modifications to the labeling.  The device, as modified, will be marketed under the trade name avitene ultrawrap collagen hemostat and is indicated for use in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.